Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Phase III study of ETEC vaccine does not meet primary clinical endpoint

April 3, 2000

Immunostimulatory sequence designed by Dynavax reduces HSV-2 severity

March 30, 2000

Development and use of gene-based multivalent malaria vaccine

March 28, 2000

Glaxo Wellcome expands DNA vaccine program with PowderJect

March 28, 2000

Siga acquires Chlamydia vaccine technology from Oregon State University

March 27, 2000

Vasogen cleared to proceed with clinical trial of VAS-981 in leukemia patients

March 24, 2000

IND filed with FDA for ISAtx-247

March 23, 2000

Effects of TAK-603 on cytokine production reported at Japanese congress

March 22, 2000

Medinox's NO neutralizer prevents transplant rejection in preclinical study

March 21, 2000

Whole genome sequencing of N. meningitidis leads to novel vaccine candidates

March 20, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...